{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T02:14:35Z","timestamp":1794968075658,"version":"4.9.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,12,4]],"date-time":"2017-12-04T00:00:00Z","timestamp":1512345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,12,4]],"date-time":"2017-12-04T00:00:00Z","timestamp":1512345600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Despite novel therapies, relapse of multiple myeloma (MM) is virtually inevitable. Amplification of chromosome 1q, which harbors the inflammation-responsive RNA editase adenosine deaminase acting on RNA (ADAR)1 gene, occurs in 30\u201350% of MM patients and portends a poor prognosis. Since adenosine-to-inosine RNA editing has recently emerged as a driver of cancer progression, genomic amplification combined with inflammatory cytokine activation of ADAR1 could stimulate MM progression and therapeutic resistance. Here, we report that high ADAR1 RNA expression correlates with reduced patient survival rates in the MMRF CoMMpass data set. Expression of wild-type, but not mutant, ADAR1 enhances Alu-dependent editing and transcriptional activity of GLI1, a Hedgehog (Hh) pathway transcriptional activator and self-renewal agonist, and promotes immunomodulatory drug resistance in vitro. Finally, ADAR1 knockdown reduces regeneration of high-risk MM in serially transplantable patient-derived xenografts. These data demonstrate that ADAR1 promotes malignant regeneration of MM and if selectively inhibited may obviate progression and relapse.<\/jats:p>","DOI":"10.1038\/s41467-017-01890-w","type":"journal-article","created":{"date-parts":[[2017,11,28]],"date-time":"2017-11-28T19:19:26Z","timestamp":1511896766000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":117,"title":["Alu-dependent RNA editing of GLI1 promotes malignant regeneration in multiple myeloma"],"prefix":"10.1038","volume":"8","author":[{"given":"Elisa","family":"Lazzari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phoebe K.","family":"Mondala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel Delos","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber C.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Pineda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingfei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Leu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn A.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anusha-Preethi","family":"Ganesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina N.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin","family":"Costello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Minden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Chiaramonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.\u00a0 Keith","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie A.","family":"Crews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catriona H. M.","family":"Jamieson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,12,4]]},"reference":[{"key":"1890_CR1","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1182\/blood-2006-03-009910","volume":"108","author":"I Hanamura","year":"2006","unstructured":"Hanamura, I. et al. Frequent gain of chromosome band 1q21 in plasma-cell dyscrasias detected by fluorescence in situ hybridization: incidence increases from MGUS to relapsed myeloma and is related to prognosis and disease progression following tandem stem-cell transplantation. Blood \n                           108, 1724\u20131732 (2006).","journal-title":"Blood"},{"key":"1890_CR2","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.bbmt.2009.11.025","volume":"16","author":"P Nemec","year":"2010","unstructured":"Nemec, P. et al. Gain of 1q21 is an unfavorable genetic prognostic factor for multiple myeloma patients treated with high-dose chemotherapy. Biol. Blood Marrow Transplant. \n                           16, 548\u2013554 (2010).","journal-title":"Biol. Blood Marrow Transplant."},{"key":"1890_CR3","doi-asserted-by":"publisher","first-page":"12174","DOI":"10.1073\/pnas.1006183107","volume":"107","author":"N Paz-Yaacov","year":"2010","unstructured":"Paz-Yaacov, N. et al. Adenosine-to-inosine RNA editing shapes transcriptome diversity in primates. Proc. Natl Acad. Sci. USA \n                           107, 12174\u201312179 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1890_CR4","doi-asserted-by":"publisher","first-page":"5376","DOI":"10.1128\/MCB.15.10.5376","volume":"15","author":"JB Patterson","year":"1995","unstructured":"Patterson, J. B. & Samuel, C. E. Expression and regulation by interferon of a double-stranded-RNA-specific adenosine deaminase from human cells: evidence for two forms of the deaminase. Mol. Cell Biol. \n                           15, 5376\u20135388 (1995).","journal-title":"Mol. Cell Biol."},{"key":"1890_CR5","first-page":"997","volume":"29","author":"G Bianchi","year":"2014","unstructured":"Bianchi, G. & Ghobrial, I. M. Biological and clinical implications of clonal heterogeneity and clonal evolution in multiple myeloma. Curr. Cancer Ther. Rev. \n                           29, 997\u20131003 (2014).","journal-title":"Curr. Cancer Ther. Rev."},{"key":"1890_CR6","doi-asserted-by":"crossref","unstructured":"Colombo, M. et al. Multiple myeloma-derived Jagged ligands increases autocrine and paracrine interleukin-6 expression in bone marrow niche. Oncotarget \n                           7,\u00a056013-56029\u00a0(2016).","DOI":"10.18632\/oncotarget.10820"},{"key":"1890_CR7","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nrc.2017.23","volume":"17","author":"Q Jiang","year":"2017","unstructured":"Jiang, Q., Crews, L. A., Holm, F. & Jamieson, C. H. M. RNA editing-dependent epitranscriptome diversity in cancer stem cells. Nat. Rev. Cancer \n                           17, 381\u2013392 (2017).","journal-title":"Nat. Rev. Cancer"},{"key":"1890_CR8","doi-asserted-by":"crossref","unstructured":"Crews, L. A., et al. RNA splicing modulation selectively impairs leukemia stem cell maintenance in secondary human AML. Cell Stem Cell \n                           19, 599-612 (2016).","DOI":"10.1016\/j.stem.2016.08.003"},{"key":"1890_CR9","doi-asserted-by":"crossref","unstructured":"Dup\u00e9r\u00e9-Richer, D. & Licht, J. D. Epigenetic regulatory mutations and epigenetic therapy for multiple myeloma. Curr. Opin. Hematol. 24, 336\u2013344 (2017).","DOI":"10.1097\/MOH.0000000000000358"},{"key":"1890_CR10","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.ccell.2015.08.013","volume":"28","author":"L Han","year":"2015","unstructured":"Han, L. et al. The genomic landscape and clinical relevance of A-to-I RNA editing in human cancers. Cancer Cell \n                           28, 515\u2013528 (2015).","journal-title":"Cancer Cell"},{"key":"1890_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.stem.2016.05.004","volume":"19","author":"MA Zipeto","year":"2016","unstructured":"Zipeto, M. A. et al. ADAR1 activation drives leukemia stem cell self- renewal by impairing Let-7 biogenesis. Cell Stem Cell \n                           19, 1\u201315 (2016).","journal-title":"Cell Stem Cell"},{"key":"1890_CR12","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1073\/pnas.1213021110","volume":"110","author":"Q Jiang","year":"2013","unstructured":"Jiang, Q. et al. ADAR1 promotes malignant progenitor reprogramming in chronic myeloid leukemia. Proc. Natl Acad. Sci. USA \n                           110, 1041\u20131046 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1890_CR13","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1038\/sj.leu.2404403","volume":"20","author":"R Fonseca","year":"2006","unstructured":"Fonseca, R. et al. Prognostic value of chromosome 1q21 gain by fluorescent in situ hybridization and increase CKS1B expression in myeloma. Leukemia \n                           20, 2034\u20132040 (2006).","journal-title":"Leukemia"},{"key":"1890_CR14","doi-asserted-by":"crossref","unstructured":"Anad\u00f3n, C. et al. Gene amplification-associated overexpression of the RNA editing enzyme ADAR1 enhances human lung tumorigenesis. Oncogene \n                           35, 4407\u20134013 (2015).","DOI":"10.1038\/onc.2015.469"},{"key":"1890_CR15","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.ccr.2006.03.019","volume":"9","author":"DR Carrasco","year":"2006","unstructured":"Carrasco, D. R. et al. High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patients. Cancer Cell \n                           9, 313\u2013325 (2006).","journal-title":"Cancer Cell"},{"key":"1890_CR16","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/nature09837","volume":"471","author":"MA Chapman","year":"2011","unstructured":"Chapman, M. A. et al. Initial genome sequencing and analysis of multiple myeloma. Nature \n                           471, 467\u2013472 (2011).","journal-title":"Nature"},{"key":"1890_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-014-0370-3","volume":"13","author":"LA Crews","year":"2015","unstructured":"Crews, L. A. et al. An RNA editing fingerprint of cancer stem cell reprogramming. J. Transl. Med. \n                           13, 1\u201312 (2015).","journal-title":"J. Transl. Med."},{"key":"1890_CR18","doi-asserted-by":"publisher","first-page":"4048","DOI":"10.1073\/pnas.0611682104","volume":"104","author":"CD Peacock","year":"2007","unstructured":"Peacock, C. D. et al. Hedgehog signaling maintains a tumor stem cell compartment in multiple myeloma. Proc. Natl Acad. Sci. USA \n                           104, 4048\u20134053 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1890_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1182\/blood-2011-07-368142","volume":"120","author":"S Blotta","year":"2012","unstructured":"Blotta, S. et al. Canonical and non canonical Hedgehog pathway in the pathogenesis of multiple myeloma. Blood \n                           120, 1\u20134 (2012).","journal-title":"Blood"},{"key":"1890_CR20","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1182\/blood-2014-03-557298","volume":"124","author":"Z Liu","year":"2014","unstructured":"Liu, Z. et al. A critical role of autocrine sonic hedgehog signaling in human CD138+ myeloma cell survival and drug resistance. Blood \n                           124, 2061\u20132072 (2014).","journal-title":"Blood"},{"key":"1890_CR21","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1038\/nm1614","volume":"13","author":"C Dierks","year":"2007","unstructured":"Dierks, C. et al. Essential role of stromally induced hedgehog signaling in B-cell malignancies. Nat. Med. \n                           13, 944\u2013951 (2007).","journal-title":"Nat. Med."},{"key":"1890_CR22","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/nature07737","volume":"458","author":"C Zhao","year":"2009","unstructured":"Zhao, C. et al. Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia. Nature \n                           458, 776\u2013779 (2009).","journal-title":"Nature"},{"key":"1890_CR23","doi-asserted-by":"crossref","unstructured":"Sadarangani, A. et al. GLI2 inhibition abrogates human leukemia stem cell dormancy. J. Transl. Med. 13, 98 (2015).","DOI":"10.1186\/s12967-015-0453-9"},{"key":"1890_CR24","doi-asserted-by":"publisher","first-page":"321","DOI":"10.4161\/rna.23343","volume":"10","author":"T Shimokawa","year":"2013","unstructured":"Shimokawa, T. et al. RNA editing of the GLI1 transcription factor modulates the output of Hedgehog signaling. RNA Biol. \n                           10, 321\u2013333 (2013).","journal-title":"RNA Biol."},{"key":"1890_CR25","doi-asserted-by":"publisher","first-page":"9876","DOI":"10.1093\/nar\/gks691","volume":"40","author":"C Daniel","year":"2012","unstructured":"Daniel, C., Ven\u00f8, M. T., Ekdahl, Y., Kjems, J. & Marie, O. A distant cis acting intronic element induces site-selective RNA editing. Nucleic Acids Res. \n                           40, 9876\u20139886 (2012).","journal-title":"Nucleic Acids Res."},{"key":"1890_CR26","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1152\/ajpgi.00512.2009","volume":"299","author":"C Xiao","year":"2010","unstructured":"Xiao, C. et al. Hedgehog signaling regulates E-cadherin expression for the maintenance of the actin cytoskeleton and tight junctions. Am. J. Physiol. Gastrointest. Liver Physiol. \n                           299, 1252\u20131265 (2010).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"1890_CR27","doi-asserted-by":"publisher","first-page":"4874","DOI":"10.1038\/onc.2011.195","volume":"30","author":"RR Singh","year":"2011","unstructured":"Singh, R. R. et al. ABCG2 is a direct transcriptional target of Hedgehog signaling and involved in stroma-induced drug tolerance in diffuse large B-cell lymphom. Oncogene \n                           30, 4874\u20134886 (2011).","journal-title":"Oncogene"},{"key":"1890_CR28","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.stem.2012.12.011","volume":"12","author":"DJ Goff","year":"2013","unstructured":"Goff, D. J. et al. A Pan-BCL2 inhibitor renders bone-marrow-resident human leukemia stem cells sensitive to tyrosine kinase inhibition. Cell Stem Cell \n                           12, 316\u2013328 (2013).","journal-title":"Cell Stem Cell"},{"key":"1890_CR29","doi-asserted-by":"publisher","first-page":"e39725","DOI":"10.1371\/journal.pone.0039725","volume":"7","author":"W Ma","year":"2012","unstructured":"Ma, W. et al. NOTCH1 signaling promotes human T-cell acute lymphoblastic leukemia initiating cell regeneration in supportive niches. PLoS ONE \n                           7, e39725 (2012).","journal-title":"PLoS ONE"},{"key":"1890_CR30","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1182\/blood-2013-09-529800","volume":"123","author":"I Frigyesi","year":"2014","unstructured":"Frigyesi, I. et al. Robust isolation of malignant plasma cells in multiple myeloma. Blood \n                           123, 1336\u20131340 (2014).","journal-title":"Blood"},{"key":"1890_CR31","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1038\/leu.2012.140","volume":"26","author":"D Kim","year":"2012","unstructured":"Kim, D., Park, C. Y., Medeiros, B. C. & Weissman, I. L. CD19-CD45 low\/\u2212 CD38 high\/CD138+ plasma cells enrich for human tumorigenic myeloma cells. Leukemia \n                           26, 2530\u20132537 (2012).","journal-title":"Leukemia"},{"key":"1890_CR32","doi-asserted-by":"publisher","first-page":"e71776","DOI":"10.1371\/journal.pone.0071776","volume":"8","author":"A Rihani","year":"2013","unstructured":"Rihani, A. et al. Effective Alu repeat based RT-Qpcr normalization in cancer cell perturbation experiments. PLoS ONE \n                           8, e71776 (2013).","journal-title":"PLoS ONE"},{"key":"1890_CR33","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.1752-8062.2010.00199.x","volume":"3","author":"M Meltzer","year":"2010","unstructured":"Meltzer, M. et al. The RNA editor gene Adar1 is induced in myoblasts by inflammatory ligands and buffers stress response. Clin. Transl. Sci. \n                           3, 73\u201380 (2010).","journal-title":"Clin. Transl. Sci."},{"key":"1890_CR34","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/j.1365-2141.2011.08689.x","volume":"154","author":"A Lopez-Girona","year":"2011","unstructured":"Lopez-Girona, A. et al. Lenalidomide downregulates the cell survival factor, interferon regulatory factor-4, providing a potential mechanistic link for predicting response. Br. J. Haematol. \n                           154, 325\u2013336 (2011).","journal-title":"Br. J. Haematol."},{"key":"1890_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3997","volume":"5","author":"N Bolli","year":"2014","unstructured":"Bolli, N. et al. Heterogeneity of genomic evolution and mutational profiles in multiple myeloma. Nat. Commun. \n                           5, 2997 (2014).","journal-title":"Nat. Commun."},{"key":"1890_CR36","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ccr.2013.12.015","volume":"25","author":"JG Lohr","year":"2014","unstructured":"Lohr, J. G. et al. Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapy. Cancer Cell \n                           25, 91\u2013101 (2014).","journal-title":"Cancer Cell"},{"key":"1890_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1021\/bi4006539","volume":"52","author":"T Eifler","year":"2013","unstructured":"Eifler, T., Pokharel, S. & Beal, P. A. RNA-Seq analysis identifies a novel set of editing substrates for human ADAR2 present in Saccharomyces cerevisiae. Biochemistry \n                           52, 1\u201327 (2013).","journal-title":"Biochemistry"},{"key":"1890_CR38","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.stem.2009.03.015","volume":"4","author":"J Gao","year":"2009","unstructured":"Gao, J. et al. Hedgehog signaling is dispensable for adult hematopoietic stem cell function. Cell Stem Cell \n                           4, 548\u2013558 (2009).","journal-title":"Cell Stem Cell"},{"key":"1890_CR39","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.1200\/JCO.2015.61.2267","volume":"33","author":"A Palumbo","year":"2015","unstructured":"Palumbo, A. et al. Revised international staging system for multiple myeloma: a report from International Myeloma Working Group. J. Clin. Oncol. \n                           33, 2863\u20132869 (2015).","journal-title":"J. Clin. Oncol."},{"key":"1890_CR40","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1093\/nar\/gkn188","volume":"36","author":"AR Gruber","year":"2008","unstructured":"Gruber, A. R., Lorenz, R., Bernhart, S. H., Neubok, R. & Hofacker, I. L. The Vienna RNA Websuite. Nucleic Acids Res. \n                           36, 70\u201374 (2008).","journal-title":"Nucleic Acids Res."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-017-01890-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-017-01890-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-017-01890-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T23:25:45Z","timestamp":1671751545000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-017-01890-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,4]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["1890"],"URL":"https:\/\/doi.org\/10.1038\/s41467-017-01890-w","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,4]]},"assertion":[{"value":"7 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1922"}}